About a-team Marketing Services
The knowledge platform for the financial technology industry

A-Team Insight Blogs

SuperDerivatives Appoints Head of Corporate Solutions

Subscribe to our newsletter

SuperDerivatives (SD), the benchmark for derivatives and leader in multi asset front office technology and valuation, has appointed Oren Cohanoff as Product Manager to lead the growth of the company’s corporate treasury system, CorporeX.

Cohanoff joins SD from Teva, the world’s largest generic pharmaceutical corporation, where he was Deputy Treasurer and Global Head of Financial Risk Management responsible for the hedging policy and execution and compliance in the treasury group for all the subsidiaries. In his eight years at Teva he relied on SuperDerivatives multi asset front office systems for its accurate pricing and position management in addition to using CorporeX itself after the product was launched. Prior to joining Teva Cohanoff was a trader for vanilla and exotic derivatives in FX and rates for Bank Leumi.

In his new role, Cohanoff will apply his extensive and proven expertise in corporate risk and exposure management as well as hedge accounting in order to drive the strategic growth and development of SuperDerivatives corporate risk management system, CorporeX.

Cohanoff comments: “The demand for corporate risk and exposure solutions has been increasingly evident as corporations become more responsive to these challenging market conditions. CorporeX is truly leading the way for a comprehensive solution, providing clarity and transparency to the corporate hedging process in addition to the pricing analytics needed to negotiate and hedge with optimal effectiveness.”

CorporeX, designed under the guidance of its corporate clients, is the next generation in corporate exposure management and risk compliance. The system consolidates all underlying exposure and hedges in addition to providing clients with the most powerful derivative analysis tools available. CorporeX’ unprecedented level of hedge discovery, analysis and trading is further enhanced by its integration with SDX, SuperDerivatives multi asset front office platform, and SD’s award winning OTC implied market data.

“At Teva we looked for various risk management systems for corporations and have never seen any system as good as CorporeX that provides the clarity and capability required to understand, report, test and advise on exposure risk,  hedge planning, hedge accounting and credit risk in all asset classes. CorporeX is truly a game change in corporate financial risk management.”

Yuval Levy, CTO, Head of Products and Analytics of SD states: “Oren Cohanoff’s experience positions him perfectly to meet the growing demand from corporate clients for comprehensive solutions. He will provide the industry knowledge needed in order to drive CorporeX to become the world’s leading financial risk management platform for corporations.”

“With the growing global need for advanced corporate risk management, CorporeX is expected to be a huge growth area for SD and I am excited to contribute to the promotion and further advancement of the system,” said Cohanoff.

Subscribe to our newsletter

Related content

WEBINAR

Upcoming Webinar: Taming the Private Markets Data Beast: Solving for Valuation, Integration, and Reporting in Alternative Investments

Date: 7th October 2026 Time: 10:00am ET / 3:00pm London / 4:00pm CET Duration: 50 minutes Institutional activity in private markets has surged as organisations’ traditional investment theses have been upended by global economic volatility, geopolitical instability and fee compression. In their search for better risk-adjusted returns, they have found a rich seam of alpha...

BLOG

NeoXam Sets Sights on Narrowing Private Data Gap Between GPs and LPs

As demand for private markets data accelerates, asset allocators are finding themselves having to play digital catch up with their investor counterparts. General partners (GPs), who manage private funds and allocate capital invested by limited partners (LPs) have found themselves technologically behind the curve as institutional investors plough into the once-niche markets. But because LPs are...

EVENT

AI in Capital Markets Summit London

Now in its 3rd year, the AI in Capital Markets Summit returns with a focus on the practicalities of onboarding AI enterprise wide for business value creation. Whilst AI offers huge potential to revolutionise capital markets operations many are struggling to move beyond pilot phase to generate substantial value from AI.

GUIDE

AI in Capital Markets Handbook 2026

AI adoption in capital markets has moved into a more disciplined phase. The priority is now controlled deployment: where AI can be used safely, where it can deliver measurable value, and how outputs can be governed, monitored and evidenced. The 2026 edition of the AI in Capital Markets Handbook examines how AI is being applied...